Clinical Trial Update: Varenicline to Reduce Alcohol Consumption in Heavy Drinkers [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial results from Phase 1 and Phase 2 studies assess varenicline for reducing alcohol consumption in heavy drinkers; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Vijay Ramchandani, Ph.D. | Conditions: Alcohol Drinking | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-08-15